When patients experience acute kidney injury (AKI) — sudden kidney failure or damage — in the hospital, they are at increased risk of death and other adverse events. Theoretically, if clinicians could predict which patients were at risk of these outcomes...
The U.S. Food and Drug Administration (FDA) has awarded Yale and Mayo Clinic a grant up to $6.7 million over two years to establish a Center of Excellence in Regulatory Science and Innovation (CERSI).The award will support a collaboration bridging the...
In a new study, Yale researchers identified a novel genetic defect that prevents brain tumor cells from repairing damaged DNA. They found that the defect is highly sensitive to an existing FDA-approved drug used to treat ovarian cancer — a discovery that...
